Lee, R. J., Rothwell, D. G., Smith, N., Chow, S., Delgado-SanMartin, J., Mistry, H., Sylvestre, Y., Chiang, S., Clarke, H., Gremel, G., Gupta, A., Hockenhull, K., Kelso, N., Kochhar, R., Mullan, D., Plummer, R., Serra, P., Shaw, H., Summersgill, H., Turajlic, S., Mouliere, F., Marais, R., Dive, C., Lorigan, P. (2026). Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial. Nature Communications. https://doi.org/10.1038/s41467-026-72735-8